Evaluation of serum carcinoembryonic antigen monitoring in the follow-up of colorectal cancer patients with metastatic lymph nodes and a normal preoperative serum level

International Journal of Biological Markers

Volumn 12, Issue 1, 1997, Pages 18-21

  Tobaruela, E ^a   Enriquez, J M ^a   Diez, M ^a   Camunas, J ^a   Muguerza, J ^a   Granell, J ^a  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

Carcinoembryonic antigen; Colorectal cancer; Follow up; Recurrence

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER RECURRENCE; CLINICAL TRIAL; COLORECTAL CANCER; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION;

EID: 0031007251     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460089701200104     Document Type: Article

References (15)

1. Vignati PV, Roberts PL. Preoperative evaluation and postoperative surveillance for patients with colorectal adenocarcinoma. Surg Clin North Am 1993; 73: 67-82.
2. Vernava AM, Longo WE, Virgo KS, Coplin MA, Wade TP, Johnson FE. Current follow up strategies after resection of colon cancer. Dis Colon Rectum 1994; 37: 573-83.
3. Devesa M, Morales V, Enriquez JM, Nuño J, Camuñas J, Hernandez MJ, Avila MC. Colorectal cancer. The basis for a comprehensive follow-up. Dis Colon Rectum 1988; 31: 636-52.
4. August DA, Ottow RT, Sugarbaker PH. Clinical perspective of human colorectal metastasis. Cancer Metastasis Rev 1984; 3: 303-24.
5. Bruinvels DJ, Stiggelbout AM, Kievit J, von Houwelingen HC, Habbema DF, van de Velde CJ. Follow up of patients with colorectal cancer. A meta-analysis. Ann Surg 1994; 219: 174-82.
6. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen MS. An evaluation of the carcinoembryonic antigen test for monitoring patients with resected colon cancer. JAMA 1993; 270: 943-7.
7. Kievit J, van de Velde CJ. Utility and cost of carcinoembryonic antigen monitoring in colon cancer follow up evaluation. Cancer 1990; 65: 2580-7.
8. Fletcher RH. CEA monitoring after surgery for colorectal cancer. When is the evidence sufficient? JAMA 1993; 270: 987-8.
9. McCall JL, Black RB, Rich CA, Harvey JR, Baker RA, Watts JM, Toouli J. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum 1994; 37: 875-81.
10. Rognum TO. A new approach in carcinoembryonic antigen guided follow up of large bowel carcinoma patients. Scand J Gastroenterol 1986; 21: 641-9.
11. Kane MJ. Adjuvant systemic treatment for carcinoma of the colon and rectum. Semin Oncol 1991; 18: 421-42.
12. Moertel C, Fleming T, Macdonald J, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990; 322: 352-8.
13. Krook J, Moertel C, Gunderson L, et al. Effective surgical adjuvant therapy for high risk rectal carcinoma. N Engl J Med 1991; 324: 709-15.
14. Wang JY, Tang R, Chiang JM. Value of carcinoembryonic antigen in the management of colorectal cancer. Dis Colon Rectum 1994; 37: 272-7.
15. Camuñas J, Enriquez JM, Devesa JM, Morales V, Millán I. Value of follow-up in the management of recurrent colorectal cancer. Eur J Surg Oncol 1991; 17: 530-5.